Operating Expenses Summary of BioSyent Inc.

BioSyent Inc.'s latest annual operating expenses in 2023 was 17.6 Million CAD , up 10.39% from previous year.
BioSyent Inc.'s latest quarterly operating expenses in 2024 Q2 was 4.99 Million CAD , up 30.53% from previous quarter.
BioSyent Inc. reported a annual operating expenses of 15.95 Million CAD in annual operating expenses 2022, up 10.85% from previous year.
BioSyent Inc. reported a annual operating expenses of 14.39 Million CAD in annual operating expenses 2021, up 17.01% from previous year.
BioSyent Inc. reported a quarterly operating expenses of 3.94 Million CAD for 2024 Q1, down -22.28% from previous quarter.
BioSyent Inc. reported a quarterly operating expenses of 5.07 Million CAD for 2023 Q4, up 18.08% from previous quarter.

Annual Operating Expenses Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Operating Expenses of BioSyent Inc. (2023 - 1997)

Year	Operating Expenses	Operating Expenses Growth
2023	17.6 Million CAD	10.39%
2022	15.95 Million CAD	10.85%
2021	14.39 Million CAD	17.01%
2020	12.29 Million CAD	9.24%
2019	11.25 Million CAD	15.12%
2018	9.77 Million CAD	1.92%
2017	9.59 Million CAD	14.6%
2016	8.37 Million CAD	18.73%
2015	7.05 Million CAD	33.66%
2014	5.27 Million CAD	41.25%
2013	3.73 Million CAD	43.69%
2012	2.59 Million CAD	53.91%
2011	1.68 Million CAD	42.75%
2010	1.18 Million CAD	25.1%
2009	945.88 Thousand CAD	0.95%
2008	937.01 Thousand CAD	1.54%
2007	922.8 Thousand CAD	37.83%
2006	669.52 Thousand CAD	37.62%
2005	486.51 Thousand CAD	-35.32%
2004	752.21 Thousand CAD	-15.77%
2003	893.02 Thousand CAD	11.53%
2002	800.67 Thousand CAD	-6.87%
2001	859.76 Thousand CAD	-8.06%
2000	935.16 Thousand CAD	3.91%
1999	900 Thousand CAD	-40.0%
1998	1.5 Million CAD	50.0%
1997	1 Million CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	4.99 Million CAD	30.53%
2024 Q1	3.94 Million CAD	-22.28%
2023 Q4	5.07 Million CAD	18.08%
2023 Q1	3.88 Million CAD	-19.12%
2023 Q3	4.29 Million CAD	-8.52%
2023 FY	17.6 Million CAD	10.39%
2023 Q2	4.69 Million CAD	20.92%
2022 Q2	3.91 Million CAD	13.76%
2022 Q1	3.43 Million CAD	0.85%
2022 Q3	3.79 Million CAD	-2.86%
2022 Q4	4.8 Million CAD	26.33%
2022 FY	15.95 Million CAD	10.85%
2021 Q2	4.27 Million CAD	20.86%
2021 Q3	3.16 Million CAD	-25.87%
2021 Q4	3.4 Million CAD	7.61%
2021 Q1	3.53 Million CAD	6.51%
2021 FY	14.39 Million CAD	17.01%
2020 FY	12.29 Million CAD	9.24%
2020 Q3	3.24 Million CAD	16.3%
2020 Q1	2.93 Million CAD	4.69%
2020 Q4	3.32 Million CAD	2.18%
2020 Q2	2.79 Million CAD	-4.72%
2019 Q2	3.25 Million CAD	37.78%
2019 FY	11.25 Million CAD	15.12%
2019 Q3	2.83 Million CAD	-13.01%
2019 Q4	2.8 Million CAD	-1.14%
2019 Q1	2.36 Million CAD	-4.95%
2018 Q4	2.48 Million CAD	-4.09%
2018 Q2	2.51 Million CAD	15.06%
2018 FY	9.77 Million CAD	1.92%
2018 Q1	2.18 Million CAD	-25.87%
2018 Q3	2.59 Million CAD	3.19%
2017 Q3	2.5 Million CAD	10.9%
2017 FY	9.59 Million CAD	14.6%
2017 Q4	2.94 Million CAD	17.64%
2017 Q2	2.25 Million CAD	19.88%
2017 Q1	1.88 Million CAD	-18.99%
2016 Q2	2.13 Million CAD	17.92%
2016 Q4	2.32 Million CAD	10.65%
2016 Q1	1.81 Million CAD	-13.52%
2016 Q3	2.1 Million CAD	-1.53%
2016 FY	8.37 Million CAD	18.73%
2015 Q1	1.29 Million CAD	-4.02%
2015 Q2	1.7 Million CAD	31.41%
2015 FY	7.05 Million CAD	33.66%
2015 Q4	2.09 Million CAD	6.57%
2015 Q3	1.96 Million CAD	15.5%
2014 Q4	1.34 Million CAD	-7.43%
2014 Q3	1.45 Million CAD	17.58%
2014 Q2	1.23 Million CAD	0.48%
2014 Q1	1.23 Million CAD	13.2%
2014 FY	5.27 Million CAD	41.25%
2013 Q1	755.54 Thousand CAD	3.9%
2013 Q2	864.99 Thousand CAD	14.49%
2013 Q3	1.02 Million CAD	18.61%
2013 Q4	1.08 Million CAD	6.15%
2013 FY	3.73 Million CAD	43.69%
2012 Q4	727.19 Thousand CAD	-9.05%
2012 Q3	799.5 Thousand CAD	27.02%
2012 Q2	629.42 Thousand CAD	41.64%
2012 Q1	444.37 Thousand CAD	8.61%
2012 FY	2.59 Million CAD	53.91%
2011 Q1	348.13 Thousand CAD	28.3%
2011 FY	1.68 Million CAD	42.75%
2011 Q4	409.14 Thousand CAD	-23.46%
2011 Q3	534.53 Thousand CAD	42.72%
2011 Q2	374.52 Thousand CAD	7.58%
2010 Q1	252.38 Thousand CAD	3.29%
2010 Q4	271.34 Thousand CAD	-18.88%
2010 Q3	334.48 Thousand CAD	2.88%
2010 Q2	325.1 Thousand CAD	28.81%
2010 FY	1.18 Million CAD	25.1%
2009 Q1	235.26 Thousand CAD	35.51%
2009 Q4	244.33 Thousand CAD	6.1%
2009 Q2	235.99 Thousand CAD	0.31%
2009 Q3	230.28 Thousand CAD	-2.42%
2009 FY	945.88 Thousand CAD	0.95%
2008 FY	937.01 Thousand CAD	1.54%
2008 Q4	173.61 Thousand CAD	-31.35%
2008 Q3	252.89 Thousand CAD	-0.78%
2008 Q2	254.89 Thousand CAD	-0.28%
2008 Q1	255.61 Thousand CAD	24.53%
2007 Q2	262.42 Thousand CAD	15.52%
2007 FY	922.8 Thousand CAD	37.83%
2007 Q1	227.16 Thousand CAD	-11.68%
2007 Q4	205.27 Thousand CAD	-9.94%
2007 Q3	227.94 Thousand CAD	-13.14%
2006 Q1	128.84 Thousand CAD	-82.33%
2006 FY	669.52 Thousand CAD	37.62%
2006 Q4	257.2 Thousand CAD	78.18%
2006 Q3	144.35 Thousand CAD	-5.79%
2006 Q2	153.23 Thousand CAD	18.93%
2005 Q4	729.35 Thousand CAD	439.19%
2005 Q3	135.26 Thousand CAD	2.34%
2005 FY	486.51 Thousand CAD	-35.32%
2005 Q1	120.53 Thousand CAD	-36.82%
2005 Q2	132.17 Thousand CAD	9.66%
2004 Q4	190.79 Thousand CAD	-0.42%
2004 Q1	188.09 Thousand CAD	-35.7%
2004 Q2	181.74 Thousand CAD	-3.37%
2004 FY	752.21 Thousand CAD	-15.77%
2004 Q3	191.59 Thousand CAD	5.42%
2003 Q1	210.04 Thousand CAD	2.25%
2003 FY	893.02 Thousand CAD	11.53%
2003 Q4	292.52 Thousand CAD	53.98%
2003 Q3	189.98 Thousand CAD	-10.17%
2003 Q2	211.48 Thousand CAD	0.69%
2002 Q1	182.97 Thousand CAD	-39.57%
2002 Q2	212.22 Thousand CAD	15.99%
2002 Q4	205.42 Thousand CAD	8.26%
2002 FY	800.67 Thousand CAD	-6.87%
2002 Q3	189.75 Thousand CAD	-10.59%
2001 Q3	208.35 Thousand CAD	19.91%
2001 Q1	174.89 Thousand CAD	-15.58%
2001 FY	859.76 Thousand CAD	-8.06%
2001 Q4	302.76 Thousand CAD	45.31%
2001 Q2	173.75 Thousand CAD	-0.65%
2000 Q4	207.18 Thousand CAD	-13.34%
2000 Q3	239.08 Thousand CAD	19.54%
2000 Q2	200 Thousand CAD	-33.33%
2000 Q1	300 Thousand CAD	50.0%
2000 FY	935.16 Thousand CAD	3.91%
1999 Q3	200 Thousand CAD	0.0%
1999 Q4	200 Thousand CAD	0.0%
1999 Q1	200 Thousand CAD	-33.33%
1999 FY	900 Thousand CAD	-40.0%
1999 Q2	200 Thousand CAD	0.0%
1998 Q1	200 Thousand CAD	300.0%
1998 Q4	300 Thousand CAD	0.0%
1998 FY	1.5 Million CAD	50.0%
1998 Q3	300 Thousand CAD	-40.0%
1998 Q2	500 Thousand CAD	150.0%
1997 Q4	-100 Thousand CAD	-120.0%
1997 Q3	500 Thousand CAD	0.0%
1997 FY	1 Million CAD	0.0%

Peer Operating Expenses Comparison of BioSyent Inc.

Name	Operating Expenses	Operating Expenses Difference
Aequus Pharmaceuticals Inc.	2.96 Million CAD	-494.084%
CanadaBis Capital Inc.	7.1 Million CAD	-147.768%
Decibel Cannabis Company Inc.	40.44 Million CAD	56.466%
Delivra Health Brands Inc.	7.1 Million CAD	-147.691%
Entourage Health Corp.	3.7 Million CAD	-374.913%
Lifeist Wellness Inc.	17.59 Million CAD	-0.08%
Cannara Biotech Inc.	15.34 Million CAD	-14.765%
Medicure Inc.	13.98 Million CAD	-25.873%
PharmaCielo Ltd.	8.33 Million CAD	-111.331%
Rubicon Organics Inc.	14.22 Million CAD	-23.791%
Voyageur Pharmaceuticals Ltd.	1.22 Million CAD	-1342.182%

Global Stocks Search

BioSyent Inc. (RX.V)

Operating Expenses Summary of BioSyent Inc.

Annual Operating Expenses Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Operating Expenses of BioSyent Inc. (2023 - 1997)

Peer Operating Expenses Comparison of BioSyent Inc.